Official UK procurement notice
Dried Blood Spot Testing · UK public procurement notice
Authority: Midlands Partnership Foundation Trust (NHS & healthcare)
What is being bought
Published requirement descriptionDried Blood Spot Testing for Blood Bourne Viruses
CPV: Services provided by medical laboratories
The lotProcurement structure
single lot · no lot value publishedLot #1Midlands Partnership University NHS Foundation Trust (MPFT) are awarding to a provider…
Midlands Partnership University NHS Foundation Trust (MPFT) are awarding to a provider of Blood Borne Virus Testing (BBV) to support and work in partnership with their substance misuse service teams. The Trust is looking to procure a provider who is able to provide the services with testing kits, lab testing and electronic results reporting.
The Inclusion Services within MPFT have a national footprint and as such a Provider would be required to deliver across national geographic areas as required.
Presently Inclusion deliver Community Drug & Alcohol Services in the following areas:
- Buckinghamshire – multiple sites
- Hampshire – multiple sites
- Isle of Wight
- Telford
- Staffordshire – multiple sites
The above location list outlines current locations, should the trust acquire further locations across the UK, the provider shall endeavour to accommodate these additional locations.
The provider of BBV Testing will be required to :
- Ensure that there is a consistent and affordable provision of self testing kits available;
- Ensure robust and secure information channels for the notification of results in a timely manner;
- Provide ongoing support before, during and after the testing process;
- Future proof the service to support future growth of work;
- Ensure a high quality and robust analytical service;
- Provide flexibility to meet changing service demands;
- Provide coverage on a national geographic basis.
The Trust require the following to be available to test through a *dry blood spot testing method:
- HBSAg & HBcAb
- HIV (1&2)
- Hep C AB
- HEP C PCR (to be automatically tested if Hep C Ab is positive)
MPFT intend to award this contract to an existing provider following direct award process C.
The approximate lifetime value of this contract is £336,839.19 for a 2 year term with an option to extend for up to 12 months.
This contract will begin 1st September 2026 and the maximum expiry date will be 31st August 2029.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 13 Aug 2026, 13:40 BST
- Last source update
- 13 Aug 2026, 13:40 BST
- Authority reference
RRE-01232- FTS notice number
2026/S 000-077254- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-06e3a2Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 25th August 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
- Review procedure
All appeals should be raised in line with the prevailing legislation.
Publisher note: This is a Provider Selection Regime (PSR) Intention to award notice. The awarding of this contract is subject to the Health Care services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 25th August 2026. This contract has not yet formally been awarded; this notice services as intention to award under the PSR. To ensure the provider still meets the specification this has been assessed by clinical and operational colleagues as key decision makers. There are no identified conflicts of interest. This existing provider is satisfying the original contract and will likely satisfy the proposed contract
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Sheffield Teaching Hospitals NHS Foundation TrustDried Blood Spot Testing for Blood Bourne Virus's | — | — | Awarded |
Contracts
Dried Blood Spot Testing for Blood Bourne Virus's · Sheffield Teaching Hospitals NHS Foundation Trust
- Signed
- 13 Aug 2026
- Value
- —
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| Midlands Partnership University NHS Foundation Trust (MPFT) are awarding to a provider… | — | — | — | £336,839 – £336,839 |
| Whole notice | — | — | — | £336,839 – £336,839 |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Midlands Partnersip NHS Foundation TrustReview body
Bidders & participating suppliers
1 commercial party on the notice- Sheffield Teaching Hospitals NHS Foundation TrustAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.